Moehler, M., Eimermacher, A., Siebler, J., Höhler, T., Wein, A., Menges, M., . . . Heike, M. (2005). Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer. Nature Publishing Group.
Chicago Style CitationMoehler, M., et al. Randomised Phase II Evaluation of Irinotecan Plus High-dose 5-fluorouracil and Leucovorin (ILF) Vs 5-fluorouracil, Leucovorin, and Etoposide (ELF) in Untreated Metastatic Gastric Cancer. Nature Publishing Group, 2005.
MLA CitationMoehler, M., et al. Randomised Phase II Evaluation of Irinotecan Plus High-dose 5-fluorouracil and Leucovorin (ILF) Vs 5-fluorouracil, Leucovorin, and Etoposide (ELF) in Untreated Metastatic Gastric Cancer. Nature Publishing Group, 2005.